Table 4 Characteristics associated with mortality during follow-up in untreated HIV-infected children.

Overall

405

21

3.26

Age at baseline (years)

0.034

0.840

0.097

< 1

64

9

9.70

1

-

1

-

1

-

[1 - 2]

42

2

3.40

0.32

(0.07 - 1.48)

0.76

(0.08 - 6.38)

0.6

(0.11 - 3.23)

[2 - 5]

108

3

1.68

0.2

(0.05 - 0.74)

0.44

(0.07 - 2.70)

0.34

(0.08 - 1.39)

[5 - 10]

142

5

1.82

0.24

(0.08 - 0.71)

0.39

(0.06 - 2.31)

0.29

(0.10 - 0.80)

[10 - 15]

49

2

4.91

0.28

(0.06 - 1.29)

0.44

(0.05 - 4.26)

0.28

(0.06 - 1.19)

Immunodeficiency

0.001

0.003

0.0025

No

112

6

1.36

1

-

1

-

1

-

Yes

106

2

3.38

5.21

(1.00 - 25.60)

6.8

(1.51 - 30.57)

6.02

(1.28 - 28.42)

Unknown

98

13

8.90

13.82

(3.16 - 60.50)

12.93

(2.95 - 56.68)

12.6

(2.94 - 53.97)

Gender

0.920

0.770

0.670

Male

216

11

3.09

1

-

1

-

1

-

Female

189

10

3.45

1.05

(0.47 - 2.45)

1.15

(0.44 - 2.98)

1.22

(0.49 - 3.04)

History of a PMTCT intervention

0.019

0.590

No

267

11

2.80

1

-

1

-

Yes

65

8

6.73

2.96

(1.19 - 7.33)

0.92

(0.14 - 6.21)

Unknown

73

2

1.48

0.63

(0.14 - 2.83)

0.47

(0.11 - 2.05)

Mother known to be deceased

0.140

0.230

No

308

19

3.59

1

-

1

-

Yes

97

2

1.72

3.01

(0.71 - 12.80)

2.78

(0.53 - 14.68)

Cotrimoxazole prophylaxis at baseline

0.150

0.830

No

134

11

4.93

1

-

1

-

Yes

271

10

2.36

0.53

(0.23 - 1.25)

1.13

(0.37 - 3.43)

Follow-up Centre

0.550

Cepref

131

15

3.34

1

-

MTCT

92

6

3.05

1.33

(0.52 - 3.45)